| Bid | 5.75 |
| Market Cap | 202.14M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -0.23 |
| PE Ratio (ttm) | -26.43 |
| Forward PE | n/a |
| Analyst | Strong Buy |
| Ask | 6.17 |
| Volume | 398,518 |
| Avg. Volume (20D) | 300,552 |
| Open | 6.02 |
| Previous Close | 6.00 |
| Day's Range | 5.87 - 6.23 |
| 52-Week Range | 2.51 - 7.17 |
| Beta | undefined |
About MYO
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents wit...
Analyst Forecast
According to 4 analyst ratings, the average rating for MYO stock is "Strong Buy." The 12-month stock price forecast is $8.25, which is an increase of 35.69% from the latest price.
Next Earnings Release
Analysts project revenue of $9.90M, reflecting a 108.16% YoY growth and earnings per share of -0.02, making a -71.43% decrease YoY.
2 months ago · seekingalpha.com
Myomo, Inc. (MYO) Q3 2024 Earnings Call TranscriptMyomo, Inc. (MYO) Q3 2024 Earnings Call Transcript
2 months ago · businesswire.com
Myomo to Report Third Quarter Financial Results on November 6, 2024BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological diso...